Publications

퇴장방지의약품관리제도의 운영 현황과 약품비 분석 = Analysis of Current Status and Drug Expenditure of Drug Shortage Prevention Program

Full metadata record

DC Field Value
dc.contributor.author채수미
dc.contributor.author이의경
dc.date.accessioned2017-01-25T04:13:08Z
dc.date.available2017-01-25T04:13:08Z
dc.date.issued2008-06-30
dc.identifier.issn0513-4242
dc.identifier.urihttps://repository.kihasa.re.kr/handle/201002/25284
dc.description.abstractThis study investigated the current status and drug expenditure of the drug shortage prevention program in Korea. National health insurance claims data from 2001 to 2005 were analyzed for the drugs with inadequate supply, which were designated as shortage prevention drugs (SPDs). Drug use of SPDs have increased every year, but the average increase rate of drug expenditure for SPDs, 13.5% was lower than that for all the reimbursed drugs, 18.6%. Drugs with price increase based on production cost were more actively used than drugs with prescription incentives for doctors.
dc.format.extent5
dc.languagekor
dc.publisher대한약학회
dc.title퇴장방지의약품관리제도의 운영 현황과 약품비 분석
dc.title.alternativeAnalysis of Current Status and Drug Expenditure of Drug Shortage Prevention Program
dc.typeArticle
dc.type.localArticle(Academic)
dc.identifier.apprname학술논문평가
dc.subject.keyworddrug shortage prevention program
dc.subject.keyworddrug expenditure
dc.subject.keywordincentive
dc.subject.keywordessential drugs
dc.contributor.affiliatedAuthor채수미
dc.identifier.urlhttps://scienceon.kisti.re.kr/srch/selectPORSrchArticle.do?cn=JAKO200817963246349&SITE=CLICK
dc.citation.title약학회지
dc.citation.volume52
dc.citation.number2
dc.citation.startPage160
dc.citation.endPage164
dc.identifier.bibliographicCitation약학회지, vol. 52, no. 2, pp. 160 - 164
메타데이터 간략히 보기

링크

공유

qrcode
공유하기

아이템 조회 수, 다운로드 수

Loading...

라이선스

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.